Form 4 for TXG 10x Genomics, Inc.

Accepted 2023-04-18 00:00:00 ET · period of report 2023-04-14 · accession 0001610717-23-000013 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MT	2023-04-18	2023-04-14	TXG	Saxonov Serge	CEO, Dir	S - Sale	$53.82	-2,000	897.9K	-0.2%	-$107.6K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2023-04-14	S	D	1,641	$53.61	898,151	D	—	—	(F2) This transaction was executed in multiple trades at prices ranging from $53.12 to $54.11. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
2	Common	Class A Common Stock	2023-04-14	S	D	76	$55.28	897,792	D	—	—	(F4) This transaction was executed in multiple trades at prices ranging from $55.15 to $55.46. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
3	Common	Class A Common Stock	2023-04-14	S	D	283	$54.64	897,868	D	—	—	(F3) This transaction was executed in multiple trades at prices ranging from $54.13 to $55.08. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.